Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection

BACKGROUND AND AIMS: This study aimed to clarify the clinical picture of hepatitis C virus (HCV) carriers with normal alanine aminotransferase (CNALT) and those with ALT elevation (non‐CNALT) under direct‐acting antivirals (DAAs). METHODS: We enrolled 1002 patients with HCV (427 men, median age: 69 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshita, Satoru, Sugiura, Ayumi, Umemura, Takeji, Yamazaki, Tomoo, Fujimori, Naoyuki, Matsumoto, Akihiro, Usami, Yoko, Tanaka, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411565/
https://www.ncbi.nlm.nih.gov/pubmed/32782941
http://dx.doi.org/10.1002/jgh3.12296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411565/
https://www.ncbi.nlm.nih.gov/pubmed/32782941
http://dx.doi.org/10.1002/jgh3.12296

Ejemplares similares